I’ve seen a big increase in our understanding of psoriatic arthritis just in my time in practice. This has resulted in more specific treatments but also our ability to make a more rapid diagnosis.

Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.

In phase 3 clinical trials, tildrakizumab treatment was associated with significantly higher ACR20 response rates at week 24 compared with placebo.

Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced that the US ...

Psoriatic arthritis (PsA) causes your immune system to attack your joints, but it can also affect many other parts of your body. PsA usually comes alongside psoriasis, a similar long-term, ...

Even if you’ve had psoriatic arthritis for years, a therapist can offer new perspectives on how to manage this chronic condition. If you have psoriatic arthritis, you already know how taxing it can be ...

The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.

In 2019, BMS made a big bet on Sotyktu by deciding to keep the then-pipeline asset despite its pending acquisition of Celgene. Based on that decision, BMS sold its mega-blockbuster Otezla to Amgen for ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

Joni Kazantzis was diagnosed with psoriasis at 15 and received a psoriatic arthritis diagnosis during the pandemic. She created a blog and social platform to offer the guidance she once ...